Obese, overweight patients at risk of more severe Covid: Study
By IANS |
2 Views
Obesity.. Image Source: IANS News
Sydney, April 15 : Patients who are overweight or obese are likely to have more severe Covid-19 and are highly likely to require invasive respiratory support, a new study suggests.
The findings, published in journal Diabetes Care, indicated that Covid-19 patients with obesity were more likely to require oxygen and had a 73 per cent greater chance of needing invasive mechanical ventilation.A
Similar but more modest results were seen in overweight patients. No link was found between being overweight or obese and dying in hospital from Covid-19.
E-Mail
IMAGE: Patients who are overweight or obese have more severe COVID-19 and are highly likely to require invasive respiratory support, according to a new international study. view more
Credit: i yunmai
Patients who are overweight or obese have more severe COVID-19 and are highly likely to require invasive respiratory support, according to a new international study.
The research, led by the Murdoch Children s Research Institute (MCRI) and The University of Queensland and published in
Diabetes Care, found obese or overweight patients are at high risk for having worse COVID-19 outcomes. They are also more likely to require oxygen and invasive mechanical ventilation compared to those with a healthy weight.
2021-04-15 06:35:16 GMT2021-04-15 14:35:16(Beijing Time) Xinhua English
BEIJING, April 15 (Xinhua) China s Sinovac COVID-19 vaccine produced by Chinese company Sinovac Biotech works well with clinical coronavirus symptoms, especially in moderate-to-severe cases, Bloomberg News reported on Tuesday.
The efficacy data of about 50 percent of the vaccine is for very mild disease, requiring no treatment, Fiona Russell from the Murdoch Children s Research Institute in Melbourne was quoted as saying.
For infections requiring some medical intervention, it is about 84 percent and for moderate-to-severe COVID cases, it is 100 percent, Russell said.
Paul Griffin, a professor from the University of Queensland in Brisbane, told Bloomberg that if the vaccine is approved by relevant regulators, then I think we need to have faith that it s safe and effective in that population. Enditem
Overweight people at risk of more severe COVID symptoms: Study
We’re sorry, this service is currently unavailable. Please try again later.
Dismiss
Normal text size
Advertisement
Researchers have confirmed overweight and obese people would be at a much greater risk of developing severe COVID symptoms if they contracted the virus.
The international research group, spearheaded by the University of Queensland and the Murdoch Children’s Research Institute, found obese patients were 73 per cent more likely to need to be ventilated in an intensive care unit and also more likely to require non-invasive forms of oxygen.
Research finds overweight people are at higher risk of enveloping severe COVID symptoms.
BusinessWorld
April 14, 2021 | 5:05 pm
PHILIPPINE STAR/ MICHAEL VARCAS
The lower protection rates of Chinaâs coronavirus disease 2019 (COVID-19) vaccines have raised concerns about shots that are key to inoculation rollouts from Brazil to Indonesia, especially after their efficacy was questioned by one of the most senior Chinese health officials.
Bloomberg spoke to two experts about the vaccines, zeroing in on the Sinovac Biotech Ltd. shot, which has been the focus of a crisis in confidence after it posted efficacy levels of just above 50% in a final-stage trial in Brazil â the minimum required by leading global drug regulators. Other Chinese immunizations have delivered rates between 66% to 79%, still far below the shots developed by Pfizer Inc., Moderna Inc., and even Russiaâs Sputnik vaccine that have logged protection rates of more than 90%.